Progenics Pharma (PGNX)

4.71 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Latest Headlines

Progenics Pharmaceuticals Announces Presentation at the 2020 SNMMI Mid-Winter Meeting January 16, 2020 9:11 AM - StreetInsider Progenics Pharmaceuticals Announces Presentation at the 2020 SNMMI Mid-Winter Meeting January 16, 2020 9:10 AM - Globe NewsWire Form 425 PROGENICS PHARMACEUTICAL Filed by: Lantheus Holdings, Inc. January 10, 2020 4:34 PM - SEC Filing Form 425 PROGENICS PHARMACEUTICAL Filed by: Lantheus Holdings, Inc. January 8, 2020 5:20 PM - SEC Filing Form SC 13G/A PROGENICS PHARMACEUTICAL Filed by: EAGLE ASSET MANAGEMENT INC January 6, 2020 12:24 PM - SEC Filing Pre-Open Stock Movers 12/23: (ITCI) (CBB) (SDRL) (SLNO) (PGNX) (SRPT) (More..) December 23, 2019 8:44 AM - StreetInsider Form 8-K PROGENICS PHARMACEUTICAL For: Dec 23 December 23, 2019 7:33 AM - SEC Filing Progenics Pharma (PGNX) to Resume Trading at 7:30 am December 23, 2019 7:14 AM - StreetInsider Progenics Pharma (PGNX) Phase 3 CONDOR Trial of PyL in Prostate Cancer Achieved Primary Endpoint December 23, 2019 7:01 AM - StreetInsider Progenics Pharmaceuticals Announces Phase 3 CONDOR Trial of PyL™ in Prostate Cancer Achieved Primary Endpoint December 23, 2019 7:01 AM - StreetInsider Progenics Pharmaceuticals Announces Phase 3 CONDOR Trial of PyL™ in Prostate Cancer Achieved Primary Endpoint December 23, 2019 7:00 AM - Globe NewsWire Progenics Pharma (PGNX) Halted, News Pending December 23, 2019 6:55 AM - StreetInsider Progenics Pharmaceuticals to Announce and Host a Conference Call to Discuss Top Line Results from Phase 3 CONDOR Trial of PyL™ in Prostate Cancer on Monday, December 23rd December 22, 2019 5:01 PM - StreetInsider Progenics Pharmaceuticals to Announce and Host a Conference Call to Discuss Top Line Results from Phase 3 CONDOR Trial of PyL™ in Prostate Cancer on Monday, December 23rd December 22, 2019 5:00 PM - Globe NewsWire Form 8-K PROGENICS PHARMACEUTICAL For: Dec 13 December 19, 2019 4:03 PM - SEC Filing Form 4 PROGENICS PHARMACEUTICAL For: Dec 13 Filed by: Maeusli Heinz Christoph December 17, 2019 3:16 PM - SEC Filing Form 4 PROGENICS PHARMACEUTICAL For: Dec 13 Filed by: Maeusli Heinz Christoph December 17, 2019 3:16 PM - SEC Filing Form 4 PROGENICS PHARMACEUTICAL For: Dec 13 Filed by: Mims David W. December 17, 2019 3:16 PM - SEC Filing Form 4 PROGENICS PHARMACEUTICAL For: Dec 13 Filed by: Mims David W. December 17, 2019 3:16 PM - SEC Filing Form 4 PROGENICS PHARMACEUTICAL For: Dec 13 Filed by: MacDougall Ann L. December 17, 2019 3:16 PM - SEC Filing Form 4 PROGENICS PHARMACEUTICAL For: Dec 13 Filed by: MacDougall Ann L. December 17, 2019 3:15 PM - SEC Filing Form 4 PROGENICS PHARMACEUTICAL For: Dec 13 Filed by: Ende Eric J December 17, 2019 3:15 PM - SEC Filing Form 4 PROGENICS PHARMACEUTICAL For: Dec 13 Filed by: Ber Gerard December 17, 2019 3:15 PM - SEC Filing Form 4 PROGENICS PHARMACEUTICAL For: Dec 13 Filed by: Ende Eric J December 17, 2019 3:15 PM - SEC Filing Form 4 PROGENICS PHARMACEUTICAL For: Dec 13 Filed by: Ber Gerard December 17, 2019 3:14 PM - SEC Filing Progenics Pharmaceuticals Announces Presentations at the Radiological Society of North America (RSNA) Annual Meeting November 25, 2019 8:30 AM - Globe NewsWire Progenics Pharmaceuticals Announces Presentations at the Radiological Society of North America (RSNA) Annual Meeting November 25, 2019 8:30 AM - StreetInsider Form 8-K PROGENICS PHARMACEUTICAL For: Nov 15 November 21, 2019 4:13 PM - SEC Filing Progenics Pharma (PGNX) Announces David Mims as Interim CEO November 21, 2019 4:12 PM - StreetInsider Progenics Pharmaceuticals Appoints David Mims as Interim Chief Executive Officer November 21, 2019 4:05 PM - Globe NewsWire Progenics Pharmaceuticals Appoints David Mims as Interim Chief Executive Officer November 21, 2019 4:05 PM - StreetInsider Form 8-K PROGENICS PHARMACEUTICAL For: Nov 08 November 15, 2019 4:52 PM - SEC Filing Form 425 PROGENICS PHARMACEUTICAL Filed by: Lantheus Holdings, Inc. November 13, 2019 6:02 AM - SEC Filing Form SC 13D/A PROGENICS PHARMACEUTICAL Filed by: Altiva Management Inc. November 12, 2019 1:48 PM - SEC Filing Progenics Pharma (PGNX) CEO Mark. R. Baker Resigns November 12, 2019 6:26 AM - StreetInsider Form 8-K PROGENICS PHARMACEUTICAL For: Nov 11 November 12, 2019 6:08 AM - SEC Filing Form DEFA14A PROGENICS PHARMACEUTICAL November 8, 2019 5:22 PM - SEC Filing Progenics Pharmaceuticals Announces Delivery of Consents and Revocations to Independent Inspector of Elections November 8, 2019 4:05 PM - Globe NewsWire Progenics Pharmaceuticals Announces Delivery of Consents and Revocations to Independent Inspector of Elections November 8, 2019 4:05 PM - StreetInsider Form DFAN14A PROGENICS PHARMACEUTICAL Filed by: Altiva Management Inc. November 8, 2019 3:53 PM - SEC Filing Velan Receives Requisite Number of Written Consents to Reconstitute Majority of Progenics Board November 8, 2019 2:21 PM - BizWire Form 425 PROGENICS PHARMACEUTICAL Filed by: PROGENICS PHARMACEUTICALS INC November 7, 2019 5:07 PM - SEC Filing Form 10-Q PROGENICS PHARMACEUTICAL For: Sep 30 November 7, 2019 4:12 PM - SEC Filing Form 425 PROGENICS PHARMACEUTICAL Filed by: Lantheus Holdings, Inc. November 7, 2019 10:09 AM - SEC Filing Form 425 PROGENICS PHARMACEUTICAL Filed by: Lantheus Holdings, Inc. November 7, 2019 8:31 AM - SEC Filing Form 8-K PROGENICS PHARMACEUTICAL For: Nov 07 November 7, 2019 8:16 AM - SEC Filing Progenics Pharmaceuticals Announces Business Update And Third Quarter 2019 Financial Results November 7, 2019 8:01 AM - Globe NewsWire Progenics Pharmaceuticals Announces Business Update And Third Quarter 2019 Financial Results November 7, 2019 8:00 AM - StreetInsider Form DEFA14A PROGENICS PHARMACEUTICAL November 6, 2019 5:08 PM - SEC Filing Form 425 PROGENICS PHARMACEUTICAL Filed by: PROGENICS PHARMACEUTICALS INC November 6, 2019 5:07 PM - SEC Filing Progenics Reminds Shareholders that November 17 is the True Deadline for Velan’s Consent Solicitation November 6, 2019 8:01 AM - Globe NewsWire Progenics Reminds Shareholders that November 17 is the True Deadline for Velan’s Consent Solicitation November 6, 2019 8:00 AM - StreetInsider Form DFAN14A PROGENICS PHARMACEUTICAL Filed by: Altiva Management Inc. November 5, 2019 4:47 PM - SEC Filing Form DEFA14A PROGENICS PHARMACEUTICAL November 5, 2019 9:16 AM - SEC Filing Form 425 PROGENICS PHARMACEUTICAL Filed by: PROGENICS PHARMACEUTICALS INC November 5, 2019 9:13 AM - SEC Filing Form DFAN14A PROGENICS PHARMACEUTICAL Filed by: Altiva Management Inc. November 4, 2019 11:11 AM - SEC Filing Progenics Urges Shareholders to Reject the Risk and Uncertainty That Would be Caused by Giving Velan’s Nominees Control of the Board November 4, 2019 8:00 AM - Globe NewsWire Glass Lewis Recommends Stockholders Vote on GREEN Consent Card for Velan Nominees to Constitute Majority of Progenics Board November 4, 2019 8:00 AM - BizWire Progenics Urges Shareholders to Reject the Risk and Uncertainty That Would be Caused by Giving Velan’s Nominees Control of the Board November 4, 2019 8:00 AM - StreetInsider Form 425 PROGENICS PHARMACEUTICAL Filed by: PROGENICS PHARMACEUTICALS INC November 1, 2019 5:12 PM - SEC Filing Form 8-K PROGENICS PHARMACEUTICAL For: Oct 31 November 1, 2019 5:10 PM - SEC Filing Form 425 PROGENICS PHARMACEUTICAL Filed by: PROGENICS PHARMACEUTICALS INC November 1, 2019 5:08 PM - SEC Filing Progenics Reminds Shareholders that November 17 is the Only Deadline for Velan’s Consent Solicitation November 1, 2019 1:00 PM - Globe NewsWire Progenics Reminds Shareholders that November 17 is the Only Deadline for Velan’s Consent Solicitation November 1, 2019 1:00 PM - StreetInsider Form 425 PROGENICS PHARMACEUTICAL Filed by: Lantheus Holdings, Inc. November 1, 2019 9:03 AM - SEC Filing Form 8-K PROGENICS PHARMACEUTICAL For: Oct 29 October 30, 2019 6:23 AM - SEC Filing Form 425 PROGENICS PHARMACEUTICAL Filed by: PROGENICS PHARMACEUTICALS INC October 30, 2019 6:15 AM - SEC Filing Form 425 PROGENICS PHARMACEUTICAL Filed by: PROGENICS PHARMACEUTICALS INC October 28, 2019 5:11 PM - SEC Filing Progenics Strongly Agrees With ISS Recommendation that Velan Group SHOULD NOT Get Majority Control of the Board of Directors October 28, 2019 2:01 PM - StreetInsider Progenics Strongly Agrees With ISS Recommendation that Velan Group SHOULD NOT Get Majority Control of the Board of Directors October 28, 2019 2:00 PM - Globe NewsWire Form DFAN14A PROGENICS PHARMACEUTICAL Filed by: Altiva Management Inc. October 28, 2019 10:50 AM - SEC Filing ISS Recommends Shareholders Vote on the GREEN Consent Card for Election of Velan Nominees and Removal of Progenics CEO October 28, 2019 7:00 AM - BizWire Form DFAN14A PROGENICS PHARMACEUTICAL Filed by: Altiva Management Inc. October 24, 2019 3:04 PM - SEC Filing Independent Director Candidates Nominated by Velan Issue Letter to Progenics Shareholders October 24, 2019 2:05 PM - BizWire Form DFAN14A PROGENICS PHARMACEUTICAL Filed by: Altiva Management Inc. October 23, 2019 5:12 PM - SEC Filing Velan Responds to Misleading Communications from Progenics October 23, 2019 5:03 PM - BizWire Form 8-K PROGENICS PHARMACEUTICAL For: Oct 23 October 23, 2019 4:31 PM - SEC Filing Form 425 PROGENICS PHARMACEUTICAL Filed by: PROGENICS PHARMACEUTICALS INC October 23, 2019 4:29 PM - SEC Filing Form 425 PROGENICS PHARMACEUTICAL Filed by: PROGENICS PHARMACEUTICALS INC October 23, 2019 4:23 PM - SEC Filing Progenics Highlights Additional Serious Concerns About Velan Capital, L.P. October 23, 2019 9:56 AM - StreetInsider Progenics Highlights Additional Serious Concerns About Velan Capital, L.P. October 23, 2019 9:55 AM - Globe NewsWire Form 425 PROGENICS PHARMACEUTICAL Filed by: Lantheus Holdings, Inc. October 23, 2019 9:02 AM - SEC Filing Form DFAN14A PROGENICS PHARMACEUTICAL Filed by: Altiva Management Inc. October 22, 2019 11:33 AM - SEC Filing Velan Sends Letter to Progenics Stockholders October 22, 2019 9:00 AM - BizWire Form 425 PROGENICS PHARMACEUTICAL Filed by: PROGENICS PHARMACEUTICALS INC October 22, 2019 6:03 AM - SEC Filing Form 8-K PROGENICS PHARMACEUTICAL For: Oct 21 October 22, 2019 6:02 AM - SEC Filing Form 425 PROGENICS PHARMACEUTICAL Filed by: PROGENICS PHARMACEUTICALS INC October 21, 2019 5:05 PM - SEC Filing Form DFAN14A PROGENICS PHARMACEUTICAL Filed by: Altiva Management Inc. October 21, 2019 12:07 PM - SEC Filing Progenics Sends Letter to Shareholders October 21, 2019 8:47 AM - StreetInsider Progenics Sends Letter to Shareholders October 21, 2019 8:45 AM - Globe NewsWire Velan Issues Presentation Outlining Nominees’ Comprehensive Strategic Plan to Save Progenics October 21, 2019 8:00 AM - BizWire Form DFAN14A PROGENICS PHARMACEUTICAL Filed by: Altiva Management Inc. October 21, 2019 6:02 AM - SEC Filing Full Article List